{
  "id": "12376603daddfbdc",
  "title": "Tivic and BARDA Continue Discussions of Entolimod for Acute Radiation Syndrome on March 10",
  "description": "20260218T180000Z",
  "content": "",
  "source": "californiatelegraph.com",
  "source_url": "http://www.californiatelegraph.com/news/278875329/tivic-and-barda-continue-discussions-of-entolimod-for-acute-radiation-syndrome-on-march-10",
  "published_at": "20260218T180000Z",
  "fetched_at": "2026-02-19T00:30:34.211663+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "http://www.californiatelegraph.com/news/278875329/tivic-and-barda-continue-discussions-of-entolimod-for-acute-radiation-syndrome-on-march-10",
    "url_mobile": "",
    "title": "Tivic and BARDA Continue Discussions of Entolimod for Acute Radiation Syndrome on March 10",
    "seendate": "20260218T180000Z",
    "socialimage": "",
    "domain": "californiatelegraph.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}